LOADING DOSE (Melanotan 2) The below dosing plan is based on the vial being reconstituted with 2ml of water
These medications are administered subcutaneously and work through systemic receptor activation, independent of gallbladder function or bile storage
Retatrutide remains an investigational compound
Evidence Summary: What the Data Suggest Several phase 2 and observational studies highlight the hepatic benefits of GLP1based treatment: Reduced liver fat: Repeated findings in imaging-based studies support this effect Lower liver enzymes: Consistent reductions in ALT/AST levels Fibrosis improvement: Promising trends in noninvasive markers, though further trials are needed While the strongest evidence comes from patients with obesity or type 2 diabetes, benefits in leaner, metabolically abnormal patients are increasingly documented, suggesting broader utility
Many health professionals recommend combining both for full-body support
Health and lifestyle ripple effects among GLP-1 patients GLP-1 use is reshaping daily habits for many Americans, influencing everything from fitness routines and eating behavior to body image and consumer choices